- Home
- / Glympse Bio
Glympse Bio
Total Funding
$68.7 M
Glympse Bio Summary
Company Summary
- Overview
- Glympse Bio operates as a biotechnology company. The Company develops a proprietary, whole-genome database of enzymes and sensors capable of targeting all clinically-relevant proteases.
- Type
- Private
- Status
- Active
- Founded
- 2015
- HQ
- Cambridge, MA, US | view all locations
- Website
- https://www.glympsebio.com
- Cybersecurity rating
Table of Contents
Key People
Wendy Winckler, Chief Scientific Officer
Jessica Atkinson, Senior Vice President, Business Development
Dhaval Gosalia, Vice President, Strategy and Operations
